• Order to parcel locker

    Order to parcel locker
  • easy pay

    easy pay
  • Reduced price
  • New
Amiloid Cardiomyopathies: Clinical, Diagnostic and Therapeutic Aspects, An Issue of Heart Failure Clinics

Amiloid Cardiomyopathies: Clinical, Diagnostic and Therapeutic Aspects, An Issue of Heart Failure Clinics

9780443121432
393.07 zł
334.11 zł Save 58.96 zł Tax included
Lowest price within 30 days before promotion: 334.11 zł
Quantity
Available in 4-6 weeks

  Delivery policy

Choose Paczkomat Inpost, Orlen Paczka, DPD or Poczta Polska. Click for more details

  Security policy

Pay with a quick bank transfer, payment card or cash on delivery. Click for more details

  Return policy

If you are a consumer, you can return the goods within 14 days. Click for more details

Description
In this issue of Heart Failure Clinics, guest editors Drs. Giuseppe Limongelli, Michele Emdin, Marco Merlo, and Claudio Rapezzi bring their considerable expertise to the topic of Amyloid Cardiomyopathies:: Clinical, Diagnostic and Therapeutic Aspects. Top experts in the field discuss the role of clinical use of biomarkers in cardiac amyloidosis; cardiac magnetic resonance in the management of cardiac amyloidosis; bone scintigraphy:: strength points and pitfalls in the diagnosis of ATTR-cardiac amyloidosis; PET and cardiac amyloidosis; endomyocardial biopsy in the diagnosis of cardiac amyloidosis; and much more.
Product Details
Elsevier
100951
9780443121432
9780443121432

Data sheet

Publication date
2024
Issue number
1
Cover
hard cover
Pages count
240
Dimensions (mm)
178 x 254
Weight (g)
430
  • Amyloidosis and Amyloidogenesis: One Name, Many Diseases
    Pathophysiology of Cardiac Amyloidosis
    The Role of Echocardiography for the Clinical Diagnosis, Risk Stratification, and Management of Cardiac Amyloidosis
    Clinical Use of Biomarkers in Cardiac Amyloidosis
    Cardiovascular Magnetic Resonance in the Management of Cardiac Amyloidosis: Current and Future Clinical Applications
    The Role of Scintigraphy with Bone Radiotracers in Cardiac Amyloidosis
    Genotype-Phenotype Correlations in ATTR Amyloidosis: A Clinical Update
    Standard Therapy in Cardiac Amyloidosis: What is Known, What is “Gray”
    Tafamidis in the Treatment of ATTR-related Cardiomyopathy: Indications and Grey Zones
    Specific Therapy in Transthyretin Amyloid Cardiomyopathy: Future Perspectives Beyond Tafamidis
Comments (0)